These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2632999)

  • 21. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M; Karaman M
    Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The resistance behavior of yeast isolates from defined patient groups to 5-fluorocytosine].
    Weber S; Polak-Wyss A
    Mycoses; 1991; 34 Suppl 1():77-81. PubMed ID: 1818269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug susceptibility of 64 strains of Rhodotorula sp.
    Krzyściak P; Macura AB
    Wiad Parazytol; 2010; 56(2):167-70. PubMed ID: 20707302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect.
    Hope WW; Warn PA; Sharp A; Howard S; Kasai M; Louie A; Walsh TJ; Drusano GL; Denning DW
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3680-8. PubMed ID: 16954320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility of clinical isolates of yeasts to anti-fungal agents.
    Hussain Qadri SM; Flournoy DJ; Qadri SG; Ramirez EG
    Mycopathologia; 1986 Sep; 95(3):183-7. PubMed ID: 3773980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter comparison of a colorimetric microdilution broth method with the reference macrodilution method for in vitro susceptibility testing of yeast isolates.
    Pfaller MA; Buschelman B; Bale MJ; Lancaster M; Espinel-Ingroff A; Rex JH; Rinaldi MG
    Diagn Microbiol Infect Dis; 1994 May; 19(1):9-13. PubMed ID: 7956018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Letter: Yeasts isolated from human urinary sample. Prevalence and high resistance of Trichosporon cutaneum].
    Guinet R
    Nouv Presse Med; 1976 Aug 28-Sep 4; 5(28):1760. PubMed ID: 785383
    [No Abstract]   [Full Text] [Related]  

  • 30. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sensitivity of Candida to 5-fluorocytosine and amphotericin B].
    Pawlik B; Budak A; Macura A; Laskownicka Z
    Med Dosw Mikrobiol; 1978; 30(1):43-8. PubMed ID: 692181
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures.
    Chang HC; Chang JJ; Huang AH; Chang TC
    J Clin Microbiol; 2000 Mar; 38(3):971-6. PubMed ID: 10698982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined action of amphotericin B and 5-fluorocytosine on pathogenic yeasts susceptible to either drug alone.
    Beggs WH; Andrews FA; Sarosi GA
    Chemotherapy; 1981; 27(4):247-51. PubMed ID: 7195793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sensitivity in vitro of opportunist yeasts (Candida albicans and Torulopsis glabrata) to flucytosine and concordance curves (author's transl)].
    Slim A; Bergogne-Berezin E; Courtoux D
    Ann Biol Clin (Paris); 1978; 36(2):69-74. PubMed ID: 358866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.
    Doern GV; Tubert TA; Chapin K; Rinaldi MG
    J Clin Microbiol; 1986 Oct; 24(4):507-11. PubMed ID: 3533974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.
    Utz CJ; Shadomy S
    J Infect Dis; 1977 Jun; 135(6):970-4. PubMed ID: 325150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
    Ellis NS; Bartlett MS; Smith JW
    Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amphotericin B susceptibility testing of Candida species by flow cytometry.
    O'Gorman MR; Hopfer RL
    Cytometry; 1991; 12(8):743-7. PubMed ID: 1794254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro studies with combinations of 5-fluorocytosine and amphotericin B.
    Shadomy S; Wagner G; Espinel-Ingroff E; Davis BA
    Antimicrob Agents Chemother; 1975 Aug; 8(2):117-21. PubMed ID: 1101814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
    Ahearn DG; McGlohn MS
    J Clin Microbiol; 1984 Mar; 19(3):412-6. PubMed ID: 6325491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.